Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux
- 7 January 2003
- journal article
- clinical trial
- Published by Wiley in Clinical Endocrinology
- Vol. 58 (1) , 49-58
Abstract
Objective Androgens and other drugs that reduce plasma concentrations of high density lipoprotein (HDL) cholesterol are often considered to be pro‐atherogenic. Tibolone lowers HDL‐cholesterol by 20% ...Keywords
This publication has 44 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?Current Opinion in Lipidology, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.Journal of Clinical Investigation, 1996
- Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ1-HDLBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Reverse Cholesterol Transport in Plasma of Patients With Different Forms of Familial HDL DeficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoproteinBiochemistry, 1988